MetaADEDB 2.0 @ LMMD
Etidronic Acid
(GWBBVOVXJZATQQ-UHFFFAOYSA-L)
Structure
SMILES
CC(P(=O)(O)[O-])(P(=O)(O)[O-])O.[Na+].[Na+]
Molecular Formula:
C2H6Na2O7P2
Molecular Weight:
249.992
Log P:
-0.1158
Hydrogen Bond Acceptor:
7
Hydrogen Bond Donor:
3
TPSA:
160.57
CAS Number(s):
7414-83-7
Synonym(s)
1.
Etidronic Acid
2.
EHDP
3.
Ethanehydroxydiphosphonate
4.
Etidronate
5.
Etidronate Disodium
6.
Sodium Etidronate
7.
(1-hydroxyethylene)diphosphonic acid
8.
(1-hydroxyethylene)diphosphonic acid, Tetrapotassium Salt
9.
1,1-hydroxyethylenediphosphonate
10.
1-Hydroxyethane-1,1-Diphosphonate
11.
1-Hydroxyethylidene-1,1-Bisphosphonate
12.
Dicalcium EHDP
13.
Dicalcium Etidronate
14.
Didronel
15.
Disodium 1-Hydroxyethylene Diphosphonate
16.
Disodium Etidronate
17.
Ethanehydroxyphosphate
18.
Etidronate, Tetrapotassium Salt
19.
HEDP
20.
HEDSPA
21.
Hydroxyethanediphosphonate
22.
Hydroxyethylidene Diphosphonic Acid
23.
Phosphonic acid, (1-hydroxyethylidene)bis-, disodium salt
24.
Xidifon
25.
Xidiphon
26.
Xydiphone
27.
1 Hydroxyethane 1,1 Diphosphonate
28.
1 Hydroxyethylidene 1,1 Bisphosphonate
29.
1,1 hydroxyethylenediphosphonate
30.
1-Hydroxyethylene Diphosphonate, Disodium
31.
Diphosphonate, Disodium 1-Hydroxyethylene
32.
Diphosphonic Acid, Hydroxyethylidene
33.
Disodium 1 Hydroxyethylene Diphosphonate
34.
EHDP, Dicalcium
35.
Etidronate, Dicalcium
36.
Etidronate, Disodium
37.
Etidronate, Sodium
38.
Salt Etidronate, Tetrapotassium
39.
Tetrapotassium Salt Etidronate
External Link(s)
MeSHD012968
PubChem Compound42608872
78759292
23894
BindingDB50247999
ChEBI4906
CHEMBLCHEMBL1201042
KEGGdr:D00314
Therapeutic Target DatabaseD00XUN
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Cerebrovascular accidentFAERS: 4US FAERS
2Feeling abnormalFAERS: 3US FAERS
3Acute myocardial infarctionFAERS: 2US FAERS
4ArthralgiaFAERS: 2US FAERS
5Blood creatine phosphokinase increasedFAERS: 2US FAERS
6Blood urea increasedFAERS: 2US FAERS
7OsteomyelitisFAERS: 2US FAERS
8Pulmonary FibrosisFAERS: 2US FAERS
9APACHE II score increasedFAERS: 1US FAERS
10AbscessFAERS: 1US FAERS
11AgeusiaFAERS: 1US FAERS
12Alanine Aminotransferase IncreasedFAERS: 1US FAERS
13AnorexiaFAERS: 1US FAERS
14Aspartate Aminotransferase IncreasedFAERS: 1US FAERS
15Blood alkaline phosphatase increasedFAERS: 1US FAERS
16Blood lactate dehydrogenase increasedFAERS: 1US FAERS
17CalcinosisFAERS: 1US FAERS
18CellulitisFAERS: 1US FAERS
19CholangitisFAERS: 1US FAERS
20CholelithiasisFAERS: 1US FAERS
21Cytomegalovirus hepatitisFAERS: 1US FAERS
22DiverticulitisFAERS: 1US FAERS
23Epstein-Barr virus antigen positiveFAERS: 1US FAERS
24Gamma-Glutamyltransferase IncreasedFAERS: 1US FAERS
25Gastrointestinal carcinomaFAERS: 1US FAERS
26Intermittent ClaudicationFAERS: 1US FAERS
27Memory impairmentFAERS: 1US FAERS
28NauseaFAERS: 1US FAERS
29NervousnessFAERS: 1US FAERS
30OsteitisFAERS: 1US FAERS
31Pancreatic carcinomaFAERS: 1US FAERS
32PeriostitisFAERS: 1US FAERS
33PneumoniaFAERS: 1US FAERS
34Primary sequestrumFAERS: 1US FAERS
35Throat irritationFAERS: 1US FAERS
36ThrombocytopeniaFAERS: 1US FAERS
37Toxic Epidermal NecrolysisFAERS: 1US FAERS
38Venous occlusionFAERS: 1US FAERS
39VomitingFAERS: 1US FAERS
40Weight decreasedFAERS: 1US FAERS
41Abdominal PainCanada Vigilance: 1Canada Vigilance
42AngioedemaCanada Vigilance: 1Canada Vigilance
43AstheniaCanada Vigilance: 1Canada Vigilance
44Bone painCanada Vigilance: 1Canada Vigilance
45Chest discomfortCanada Vigilance: 1Canada Vigilance
46Drug ineffectiveCanada Vigilance: 2Canada Vigilance
47DyspepsiaCanada Vigilance: 1Canada Vigilance
48PancreatitisCanada Vigilance: 1Canada Vigilance
49PruritusCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.